{"resourceType":"ValueSet","id":"2.16.840.1.113762.1.4.1116.511","meta":{"versionId":"5","lastUpdated":"2023-04-03T15:22:30.000-04:00","profile":["http://hl7.org/fhir/StructureDefinition/shareablevalueset","http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"]},"extension":[{"url":"http://hl7.org/fhir/StructureDefinition/valueset-author","valueString":"CancerLinQ Author"},{"url":"http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate","valueDate":"2022-12-15"},{"url":"http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate","valueDate":"2023-04-03"}],"url":"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.511","identifier":[{"system":"urn:ietf:rfc:3986","value":"urn:oid:2.16.840.1.113762.1.4.1116.511"}],"version":"20180724","name":"MedicalReasonsForNotPerformingFlowCytometry","title":"Medical Reasons for Not Performing Flow Cytometry","status":"active","experimental":false,"date":"2018-07-24T01:00:01-04:00","publisher":"CancerLinQ Steward","jurisdiction":[{"coding":[{"system":"urn:iso:std:iso:3166","code":"US"}]}],"purpose":"(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )","compose":{"include":[{"system":"http://www.ama-assn.org/go/cpt","concept":[{"code":"1P","display":"Performance Measure Exclusion Modifier due to Medical Reasons"},{"code":"3170F","display":"Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"}]}]},"expansion":{"identifier":"urn:uuid:89836a8e-b550-4dda-b688-8d39aa37e63e","timestamp":"2023-12-10T21:41:45-05:00","total":2,"contains":[{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"1P","display":"Performance Measure Exclusion Modifier due to Medical Reasons"},{"system":"http://www.ama-assn.org/go/cpt","version":"2024","code":"3170F","display":"Baseline flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"}]}}